haemagglutininum influenzae A (H1N1) (Virus Stamm A/Wisconsin/67/2022 (H1N1)-like: derived from A/Georgia/12/2022 CVR-167) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/District of Columbia/27/2023 (H3N2)-like: derived from A/Victoria/800/2024-CVR-289) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Austria/1359417/2021-like: reassortant from B/Singapore/WUH4618/2021 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013-like: reassortant from B/Singapore/INFTT-16-0610/2016 (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.7 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum.
Packungsbestandteile
Injection suspension
Active Agent
Dose
Haemagglutininum Influenzae a (H1N1) (Virus Stamm A/wisconsin/67/2022 (H1N1)-Like: Derived from A/georgia/12/2022 Cvr-167)
15µg / 0.5ml
Haemagglutininum Influenzae a (H3N2) (Virus Stamm A/district of Columbia/27/2023 (H3N2)-Like: Derived from A/victoria/800/2024-Cvr-289)
15µg / 0.5ml
Haemagglutininum Influenzae b (Virus Stamm B/austria/1359417/2021-Like: Reassortant from B/singapore/wuh4618/2021 (Victoria Lineage))
15µg / 0.5ml
BAG: Active Agent
Dose
Influenza-haemagglutinin
60 mcg
Inactive agents
Dose
Haemagglutininum Influenzae b (Virus Stamm B/phuket/3073/2013-Like: Reassortant from B/singapore/inftt-16-0610/2016 (Yamagata Lineage))
15µg / 0.5ml
Potassium Chloride
Potassium Dihydrogenophosphate
Magnesium Chloride Hexahydrate
Sodium Chloride
Sodium Dihydrogenophosphate Dihydrate
Source
Data was imported : 05.09.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
